Introduction
Amphetamine mixed salts, commonly known by the brand name Adderall, are widely used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. The drug with the NDC code 64850-0841 is manufactured by Elite Laboratories, Inc. Here, we will delve into the market analysis and price projections for this specific formulation.
Market Overview
The biopharma and biotech industries are experiencing significant growth, driven by advancements in technology, evolving regulatory frameworks, and a shift towards patient-centered care. As of 2024, the biopharma market size was estimated to be over $400 billion, with a projected compound annual growth rate (CAGR) of 7.56% between 2024 and 2029[3].
Drug Specifics
- Drug Name: Amphetamine mixed salts immediate release tablets
- Manufacturer: Elite Laboratories, Inc.
- NDC Code: 64850-0841
- Dosage Forms: Available in various strengths, including 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg, and 30 mg[4].
Current Market Trends
The pharmaceutical market is witnessing several key trends that could impact the pricing and availability of amphetamine mixed salts:
Clinical Trial Innovations
Accelerated clinical trial designs are becoming more prevalent, which could lead to faster drug development and potentially affect the market dynamics of existing drugs like Adderall[3].
Regulatory Landscape
The regulatory landscape is evolving to keep pace with innovation, which may influence the approval and pricing of generic and brand-name drugs[3].
Drug Shortages
There have been reported shortages of amphetamine mixed salts immediate release tablets, which can impact pricing due to supply and demand imbalances. For instance, as of December 2024, there were shortages reported for various strengths of Adderall immediate release tablets[4].
Price Trends
To understand the price projections for NDC 64850-0841, we need to look at recent pricing data and trends:
Historical Pricing
The price of Adderall immediate release tablets has shown minor fluctuations over recent months. For example, the 30 mg tablet (NDC 57844-0130) had a price per unit of around $10.27 in December 2024, with slight variations in the preceding months[2].
Projected Price Inflation
The overall drug price inflation rate for 2025 is projected to be 3.81%, according to Vizient's summer 2024 Pharmacy Market Outlook. This general trend could influence the pricing of amphetamine mixed salts[2].
Price Projections
Given the current market trends and projected inflation rates:
- Short-Term Projections: The price of amphetamine mixed salts immediate release tablets is likely to remain stable or see a minor increase, aligning with the overall drug price inflation rate of 3.81% for 2025.
- Long-Term Projections: As the biopharma and biotech industries continue to grow, there may be increased competition from new formulations or generic alternatives, which could stabilize or even reduce prices in the long term.
Impact of Shortages
Drug shortages can significantly impact pricing due to reduced supply. If the shortages of amphetamine mixed salts continue, it could lead to temporary price increases until the supply chain is stabilized[4].
Conclusion
The market for amphetamine mixed salts, including the formulation with NDC 64850-0841, is influenced by a combination of factors such as clinical trial innovations, regulatory changes, and supply chain dynamics.
Key Takeaways
- The biopharma market is growing rapidly, with a projected CAGR of 7.56% between 2024 and 2029.
- Amphetamine mixed salts are subject to minor price fluctuations and are projected to follow the overall drug price inflation rate of 3.81% in 2025.
- Drug shortages can temporarily impact pricing.
- Long-term competition from new formulations or generic alternatives may stabilize or reduce prices.
FAQs
1. What is the current price trend for amphetamine mixed salts immediate release tablets?
The current price trend shows minor fluctuations, with prices around $10.27 per unit for the 30 mg tablet as of December 2024[2].
2. How do drug shortages affect the pricing of amphetamine mixed salts?
Drug shortages can lead to temporary price increases due to reduced supply and increased demand[4].
3. What is the projected drug price inflation rate for 2025?
The overall drug price inflation rate for 2025 is projected to be 3.81% according to Vizient's summer 2024 Pharmacy Market Outlook[2].
4. How does the evolving regulatory landscape impact the pricing of pharmaceuticals?
The evolving regulatory landscape can influence the approval and pricing of generic and brand-name drugs, potentially leading to more competitive pricing[3].
5. What are the key factors influencing the market for amphetamine mixed salts?
Key factors include clinical trial innovations, regulatory changes, supply chain dynamics, and overall market growth trends in the biopharma and biotech industries[3].
Sources
- DailyMed: Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets[1].
- DrugPatentWatch: Drug Price Trends for NDC 57844-0130[2].
- TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025[3].
- ASHP: Amphetamine Mixed Salts, Immediate-Release Tablets - Drug Shortages[4].
